Eisai Alzheimer's drug sparks hot debate over benefits as risks like brain bleeding emerge
Eisai Co.'s much-anticipated findings on its experimental Alzheimer's drug provided tinder for a debate over whether its modest efficacy is worth potential risks that include serio…
